Average Insider

Where insiders trade, we follow

TEVA PHARMACEUTICAL INDUSTRIES LTD ($TEVA)
Accession: 0001193125-26-096513
Mar 6, 2026
๐Ÿ“ˆ Chart on TradingView๐Ÿ’ฐ Financials on Finviz
52W Low$12.47
Current$29.4368.2% above low, 31.8% below high
52W High$37.35

Filing Information

Accession Number0001193125-26-096513
Form Type4
Filing DateMar 6, 2026
DocumentView SEC Filing
Transactions
5
Total Shares
166,701
Total Value
$0.00
P&L
+inf% (+$1,564,940.25)

Transactions

NameTitleSecurityDerivativeTransaction DateTypeSharesPriceTotal CostShares AfterDirect/IndirectNature of OwnershipActions
Kalif Eliyahu Sharon
EVP, Chief Financial Officer
Ordinary Shares
โ€”Mar 4, 2026Exercise/Conversion33,512โ€”โ€”282,268Directโ€”View Details
Kalif Eliyahu Sharon
EVP, Chief Financial Officer
Ordinary Shares
โ€”Mar 4, 2026Exercise/Conversion23,251โ€”โ€”305,519Directโ€”View Details
Kalif Eliyahu Sharon
EVP, Chief Financial Officer
Restricted Share Units
(Ordinary Shares)
DerivativeMar 4, 2026Exercise/Conversion33,512$0.00$0.000Directโ€”View Details
Kalif Eliyahu Sharon
EVP, Chief Financial Officer
Restricted Share Units
(Ordinary Shares)
DerivativeMar 4, 2026Exercise/Conversion23,251$0.00$0.0046,503Directโ€”View Details
Kalif Eliyahu Sharon
EVP, Chief Financial Officer
Restricted Share Units
(Ordinary Shares)
DerivativeMar 4, 2026Grant/Award53,175$0.00$0.0053,175Directโ€”View Details
Version: v26.3.23